Pacira BioSciences (PCRX) Tax Rate Growth (1y) (2015 - 2026)
Pacira BioSciences (PCRX) Tax Rate Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.82 Bn | 87.96 Bn | - |
| 2 | Teva Pharmaceutical Industries | 36.03 Bn | 32.29 Bn | 1.97 Bn |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.50 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.02 Bn | 20.86 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.43 Bn | 18.63 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.73 Bn | 12.30 Bn | 785.00 Mn |
| 10 | Pacira BioSciences | 1.08 Bn | 881.77 Mn | 140.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -307.00 |
| Dec 31, 2025 | -22,385.00 |
| Sep 30, 2025 | 4,629.00 |
| Jun 30, 2025 | -19,991.00 |
| Mar 31, 2025 | 1,056.00 |
| Dec 31, 2024 | 1,091.00 |
| Sep 30, 2024 | -3,791.00 |
| Jun 30, 2024 | 1,644.00 |
| Mar 31, 2024 | 796.00 |
| Dec 31, 2023 | -1,784.00 |
| Sep 30, 2023 | -9,890.00 |
| Jun 30, 2023 | 2,226.00 |
| Mar 31, 2023 | 1,982.00 |
| Dec 31, 2022 | 2,686.00 |
| Sep 30, 2022 | 10,638.00 |
| Jun 30, 2022 | -1,592.00 |
| Mar 31, 2022 | -1,247.00 |
| Dec 31, 2021 | 3,168.00 |
| Sep 30, 2021 | 204,287.00 |
| Jun 30, 2021 | 2,503.00 |